Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              Phase 1 Asian PK Study of ABBV-CLS-7262, an eIF2B Activator Being Developed as a Potential Treatment for Amyotrophic Lateral Sclerosis and Vanishing White Matter Disease

              Author:Han, Yi Rang   Malik, Paul   Huang, Xiu   Boiser, Joey   Jeong, Anna   Siovitz, Lucia   Stodtmann, Sven   Cho, Bill   Rosebraugh, Matthew   

              Session Name:P5: Neuromuscular and Clinical Neurophysiology (EMG): Amyotrophic Lateral Sclerosis 1  

              Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

              Program Number:P5.014  

              Author Institution:AbbVie, North Chicago, IL  Calico Life Sciences, South San Francisco, CA  AbbVie, Chicago, IL  AbbVie, Ludwigshafen Am Rhein, Germany  Calico, South San Francisco, CA